Gossamer Bio Inc Sustainability Reports
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutics. The company primarily develops treatments for pulmonary hypertension and pulmonary arterial hypertension.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300ZOC0N2W6PSFR58
FIGI: BBG00MVWLMC1
3 reports from 2018 to 2024
